Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why did the reporting for this quarter end on 1/31/2008?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Re: moxa1: Milestone

in response to
Re: moxa1
by
milestone
posted on Apr 15, 2008 09:02AM
I hope your interpretation is correct. If so, RG's statement in the shareholder letter re: "fully reflects" is misleading, at best, and should be retracted/clarified asap.
1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply